|
Market Closed -
Deutsche Boerse AG
02:06:15 2026-09-17 EDT
|
5-day change | 1st Jan Change | ||
| 11.94 EUR | +2.05% |
|
0.00% | +127.65% |
| 09-15 | French and Benelux stocks-Factors to watch on September 15 | RE |
| 09-15 | France's Genfit Plans Phase 2a Trial of Liver Failure Treatment | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENFIT | Other Biotechnology & Medical Research | +2.05% | 0.00% | +127.65% | +234.64% | +260.07% | 693M |
-
|
-
|
-
|
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
- Charts GENFIT
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
